Przejdź do zawartości
Merck
Wszystkie zdjęcia(2)

Key Documents

1.50469

Supelco

Purospher® STAR RP-18 endcapped (3 µm) HPLC Columns

L × I.D. 100 mm x 4.6 mm Hibar® RT HPLC Column

Synonim(y):

Purospher® STAR RP-18 endcapped (3µm) Hibar® RT 100-4.6

Zaloguj sięWyświetlanie cen organizacyjnych i kontraktowych


About This Item

Kod UNSPSC:
41115709
NACRES:
SB.52

product name

Purospher® STAR RP-18 endcapped (3 µm), L × I.D. 100 mm x 4.6 mm Hibar® RT HPLC column

Materiały

stainless steel column

Poziom jakości

agency

suitable for USP L1

linia produktu

Purospher®

Właściwości

endcapped

opakowanie

1 ea of

zakres etykietowania

17% Carbon loading

Parametry

400 bar pressure
65 °C max. temp.

metody

HPLC: suitable
LC/MS: suitable
mass spectrometry (MS): suitable (High)

kolumna dł. × śr. wewn.

10 cm × 4.6 mm

powierzchnia

330 m2/g

macierz

fully porous particle

grupa aktywna macierzy

C18 bonding phase

wielkość cząstki

3 μm

wielkość porów

120 Å pore size

operating pH range

1.5-10.5

metoda separacji

reversed phase
supercritical fluid (SFC)

temp. przechowywania

no temp limit

Opis ogólny

Purospher® STAR RP-18 endcapped, 3 µm HPLC columns are designed for universal use and allow the separation of basic, neutral, and metal chelating compounds with simple mobile phases and excellent peak symmetry. They are based on ultra-pure fully porous silica particles (Type B). These columns offer an outstanding stability from pH 1.5 to 10.5 over a wide temperature range, and suitability for up to 100% aqueous mobile phases. Plus, they demonstrate best all-round retention characteristics, as proven by the Tanaka test. Thanks to these features, Purospher® STAR RP-18 endcapped, 3 µm HPLC columns allow maximum flexibility to use the best chromatographic conditions for any separation including reversed phase.Purospher® STAR RP-18 endcapped, 3 µm Hibar® RT 150-4.6 is a ready to use stainless steel column suitable for connection to any HPLC system.The column dimension of 150 mm length x 4.6 mm I.D. is the optimal choice for high resolution HPLC separation of complex samples.The recommended guard column is Purospher® STAR RP-18 endcapped (5 µm) LiChroCART 4-4 part number 1.50250.0001]. For direct connection to a Hibar® RT columns the Precolumn holder for 4-4 LiChroCART cartridges, part number 1.51487.0001 can be used.Learn more about Purospher® STAR HPLC and UHPLC ColumnsLearn more about the Supelco HPLC Column portfolio and Method development:Brochure: HPLC and UHPLC Column Selection GuideBrochure: A Practical Guide to HPLC - Method Development Guide

Zastosowanie

Intended to be used in the separation of aflatoxins, aldehydes, alkaloids, antibiotics, catecholamines, explosives, oligonucleotides, esters, fat soluble vitamins, lipids, fatty acids, flavonoids, ketones, nitrosamines, nucleosides, PAHs, PCBs, peptides, pesticides, phenols, phthalates, preservatives, steroids, metabolized steroids, sulfonamides, sweeteners, and water soluble vitamins.

Cechy i korzyści

  • Ultra-pure silica (99.999%) for excellent peak symmetry
  • High separation efficiency
  • Reproducible results from run-to-run and batch-to-batch
  • Best all-round performance according to Tanaka
  • Outstanding pH stability from pH 1.5 to 10.5
  • No phase collapse when using highly aqueous mobile phases
  • Good suitability for LC-MS applications

Komentarz do analizy

Pressure: ≤ 130 bar
Theoretical Plates (N/m) (Anthracene): ≥ 120000
Symmetry (Anthracene): 0.8 - 1.4
Capacity factor (Anthracene): 4.0 - 6.0

Informacje prawne

Hibar is a registered trademark of Merck KGaA, Darmstadt, Germany
LICHROCART is a trademark of Merck KGaA, Darmstadt, Germany
Purospher is a registered trademark of Merck KGaA, Darmstadt, Germany
This page may contain text that has been machine translated.

Certyfikaty analizy (CoA)

Poszukaj Certyfikaty analizy (CoA), wpisując numer partii/serii produktów. Numery serii i partii można znaleźć na etykiecie produktu po słowach „seria” lub „partia”.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

Protokoły

Aripiprazole is an atypical antipsychotic and a partial dopamine agonist. It is primarily used in the treatment of schizophrenia, bipolar disorder, major depressive disorder, tic disorders, and irritability associated with autism. Aripiprazole was first approved by the U.S. Food and DrugAdministration in November 2002 for schizophrenia and by the European Medicines Agency in June 2004 for acute manic and mixed episodes associated with bipolar disorder.

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej